Columbia Scientists' Human Embryo Gene Editing Sparks Ethical Alarm

Executive Briefing

• Researchers used base editing to modify DNA at two genomic sites in human zygotes without therapeutic goals.
• Critics warn the study breaks an informal regulatory agreement and could enable embryo enhancement research.
• Mosaicism detected in edited embryos raises safety concerns if zygotes were ever developed to term.
• Nucleus Genomics, a controversial IVF screening company, provided financial backing for the research.
• Experts caution the findings serve as a practical guide for unethical genetic enhancement applications.